image
Chimerix, Inc. CMRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.52
-0.117 %
$ 799 M
Market Cap
-8.61
P/E
BALANCE SHEET
146 M ASSETS
-31.38%
Growth Rates
1Year -31.38%
3Years 13.24%
5Years 4.11%
7Years -6.59%
10Years -6.69%
24.3 M LIABILITIES
23.22%
Growth Rates
1Year 23.22%
3Years -9.00%
5Years 20.89%
7Years 8.87%
10Years 3.50%
122 M EQUITY
-36.96%
Growth Rates
1Year -36.96%
3Years 21.26%
5Years 2.05%
7Years -8.22%
10Years -7.82%
BALANCE SHEET DECOMPOSITION
Balance Sheet Chimerix, Inc.
image
Current Assets 136 M
Cash & Short-Term Investments 31 M
Receivables 57 K
Other Current Assets 105 M
Non-Current Assets 10.1 M
Long-Term Investments 8.48 M
PP&E 1.37 M
Other Non-Current Assets 214 K
21.27 %71.81 %5.80 %Total Assets$146.0m
Current Liabilities 23.9 M
Accounts Payable 3.94 M
Short-Term Debt 0
Other Current Liabilities 19.9 M
Non-Current Liabilities 458 K
Long-Term Debt 458 K
Other Non-Current Liabilities 0
16.19 %81.93 %Total Liabilities$24.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 31.0 27.7 25.8 15.4 47.0 16.9 81.1 18.5 51.5 20.6 128.5 110.0 19.9 13.6
Short Term Investments 0 155.2 191.5 73.0 32.0 96.6 105.4 133.0 180.6 199.7 106.1 0 9.8 5.9
Receivables 57 K 1.1 1.0 0.3 0.3 1.2 0.3 1.7 1.6 2.4 0.1 0.2 0.8 4.2
Inventory (1.7) 0 0 2.8 0 0 1 1 0 1 0 2.5 0.5 0.9
Other Current Assets 106.5 5.1 13.7 6.9 3.9 4.7 2.3 2.7 4.1 5.4 4.8 2.8 1.0 1.1
Total Current Assets 136.0 189.1 228.1 95.8 81.7 118.1 189.5 156.5 236.5 228.8 237.5 113.0 31.6 24.8
PP&E 1.4 1.7 2.2 2.7 3.0 1.2 1.2 1.9 2.8 3.0 1.3 0.3 0.4 0.6
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 8.5 21.7 48.6 2.0 0 0 0 76.7 47.4 124.0 53.0 0 0 0
Other Long Term Assets 0.2 0.3 0.4 56 K 26 K 34 K 46 K 72 K 55 K 70 K 0.1 30 K 22 K 22 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 146.0 212.8 279.3 100.5 84.7 119.4 190.7 235.2 286.8 356.0 291.9 113.4 32.0 25.4
LIABILITIES
Accounts Payable 3.9 2.9 3.0 2.8 1.3 2.4 4.7 3.8 3.9 10.5 5.9 2.2 2.0 4.1
Short Term Debt 0 0 0 14.0 0 0 0 0 0 0 4.3 5.6 4.8 0.2
Other Current Liabilities 19.9 15.6 17.4 13.1 7.2 6.8 8.3 9.4 6.2 9.7 5.3 2.4 0.9 2.5
Total Current Liabilities 23.9 18.4 20.4 29.9 8.5 9.2 13.0 13.2 10.1 20.2 17.1 10.2 7.6 6.8
Long Term Debt 0.5 1.3 2.1 2.4 2.8 0.2 0.1 0.2 0.4 0.4 0 4.3 9.9 2.4
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0.2 0.3 0.3 6.5
Total Liabilities 24.3 19.7 22.5 32.3 11.3 9.4 13.1 13.4 10.5 20.5 17.2 14.8 17.8 15.7
EQUITY
Common Stock 92 K 89 K 88 K 87 K 63 K 62 K 51 K 47 K 46 K 46 K 41 K 26 K 17 K 2 K
Retained Earnings (883.9) (795.5) (713.4) (885.6) (712.4) (668.8) (556.3) (486.8) (415.8) (339.4) (222.0) (162.7) (102.0) (93.7)
Other Accumulative Comprehensive Income/Loss 0 7 K (0.3) 21 K 0 35 K 92 K (1.0) (0.4) (0.8) 35 K (113.4) 2 K 4 K
Total Equity 121.7 193.0 256.9 68.3 73.4 110.0 177.6 221.8 276.2 335.5 274.6 98.5 14.2 9.7
Total Liabilities and Equity 146.0 212.8 279.3 100.5 84.7 119.4 190.7 235.2 286.8 356.0 291.9 113.4 32.0 25.4
SHARES OUTSTANDING
Common Shares Outstanding 89.7 88.6 87.6 84.9 62.2 55.5 48.6 47.0 46.3 43.9 33.0 19.3 9.4 9.4 9.4